More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
AUM
$105485438
P/E ratio
28.8
Dividend yield
0.746%
Expense ratio
0.68%
Beta
1.056849
Previous close
$43.10
Today's open
$43.02
Day's range
$42.50 - $43.19
52 week range
$31.84 - $47.25
Industries
Health
GRAL
Grail, Inc.
2.8%
CDNA
Caredx Inc
2.44%
NTRA
Natera Inc
2.35%
2.29%
2.19%
MRNA
Moderna Inc
2.13%
GKOS
Glaukos Corp.
2.12%
2.11%
2.07%
TEM
TEMPUS LABS
2%
Webcast: What M&A Trends Say About AI, Robotics & More
Just because rates have risen and borrowing is a bit more challenging doesn't mean M&A has stopped. Far from it, as major deals continue to help define key categories from robotics to AI and plenty in between.
ETF Trends • Nov 12, 2026

Post-Election Outlook for Health Innovation
The U.S. midterm elections left Democrats in control of both chambers. This has sparked an immediate rally for hospitals and insurers, while innovative health tech moved sharply the other way.
ETF Trends • Nov 11, 2026

3 Reasons HTEC Stands Out Among the Best Health Tech ETFs
Every day, headlines extoll the potential in AI investing, and the markets reflect that; the biggest companies in the S&P 500 include the key AI hyperscalers. Still, the impact of AI will be much deeper and more widespread than that — especially in other tech-heavy segments.
ETF Trends • Nov 5, 2026

Who's Buying the Future of AI & Robotics: 2026 M&A Report
After several years of cooling appetite for M&A and large IPOs, 2026 has seen a resurgence in both, as well as increased appetite for venture fundraising in robotics and physical AI.
ETF Trends • Nov 4, 2026

How Tempus AI Built a Defensible Data Moat in Precision Healthcare
As access to powerful general-purpose AI models expands, access alone offers limited differentiation. In precision healthcare, competitive advantage can come from combining proprietary clinical data, specialized models, and integration into diagnostic workflows.
ETF Trends • Oct 22, 2026

How to Invest in AI Drug Discovery
.Danaher (DHR), one of the world's largest providers of medical diagnostics and laboratory equipment, recently announced plans to launch its first AI-powered autonomous laboratory, scheduled to operate at commercial scale in early 2027. While market trading barely moved the stock on the announcement date, the news marks a quiet turning point for life science automation.
ETF Trends • Oct 14, 2026

How Healthcare Tech ETF HTEC Defied September's Market Turmoil
It's always exciting to see a fund perform well over the course of a month, but it's also important to understand exactly why that strong performance may be happening. Key Takeaways: September proved to be a relatively difficult month for many sectors of the equity market, including the healthcare sector.
ETF Trends • Oct 5, 2026

The Top HealthTech Questions Landing on Our Desks
Strong performance across the healthtech sector over the past two quarters has sparked renewed market interest in medical innovation. Given the volume of inquiries landing on our desks, we compiled this guide to answer a mix of the most frequent and most interesting questions we have received regarding our Healthcare Technology and Innovation Index (HTEC).
ETF Trends • Sep 30, 2026

AI & Robotics in 2026: 16 Recent Developments for Investors
If AI and robotics suddenly feel like they are moving faster, August gave investors plenty of evidence that the pace really is accelerating. We saw longer-running agents, faster and cheaper inference, AI systems reaching into laboratories and physical equipment, robots learning from fewer demonstrations, and new capital and infrastructure forming around commercial deployment.
ETF Trends • Sep 9, 2026

Why Moderna's Cancer Vaccine Matters to Investors
Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments toward individualized therapies. This evolution in medicine aims to provide treatments that are not only more effective but also carry a lower risk of adverse side effects by aligning with a patient's unique biology.
ETF Trends • Sep 2, 2026

¹ Disclosures

Open an M1 investment account to buy and sell ROBO Global Healthcare Technology and Innovation ETF commission-free¹. Build wealth for the long term using automated trading and transfers.